China said it would cut the prices of three top-selling drugs, including treatments from AstraZeneca and GlaxoSmithKline, by between as much as 67% as part of efforts to make innovative medicines more affordable.
from WSJ.com: US Business http://ift.tt/1rYSvvq
via IFTTT
No comments:
Post a Comment